My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is ...

A new study sheds light on how behavioral symptoms are related to daily functioning in people with Alzheimer’s disease.

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.

Leqembi is the first FDA-approved drug shown to slow the progression of early-stage Alzheimer’s. Medi-Cal can cover Leqembi ...

However, some research suggests that poor sleep could raise your risk of Alzheimer’s. A study published in November found ...

Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in Toronto, Canada. Chief ...

Massive proteomics database links gene variant APOE 4 to chronic inflammation.

Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...

We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...

A Finnish population study shows that signs related to Alzheimer's disease may already be found in the brain in middle age.

Alzheimer’s disease continues to rise as one of the most pressing health challenges facing aging populations today. It ...

Some breast cancer survivors may have a slightly reduced risk for Alzheimer’s disease, though the benefit appears to be ...